Brukinsa Evrópusambandið - íslenska - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Imbruvica Evrópusambandið - íslenska - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Leukeran Filmuhúðuð tafla 2 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

leukeran filmuhúðuð tafla 2 mg

aspen pharma trading limited - chlorambucilum inn - filmuhúðuð tafla - 2 mg

Fampridine Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - margvísleg sclerosis - Önnur lyf í taugakerfinu - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Udenyca Evrópusambandið - íslenska - EMA (European Medicines Agency)

udenyca

era consulting gmbh - pegfilgrastim - daufkyrningafæð - Ónæmisörvandi, , nýlendan að örva þáttum - lækkun á lengd mæði í tengslum og tíðni hita og mæði í tengslum í fullorðinn sjúklinga með frumudrepandi lyfjameðferð fyrir illkynja (með undantekning langvarandi merg hvítblæði og myelodysplastic heilkennum).

Omnipaque Stungulyf, lausn 350 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 350 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 350 mg j/ml

Omnipaque Stungulyf, lausn 300 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 300 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 300 mg j/ml

Omnipaque Stungulyf, lausn 180 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 180 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 180 mg j/ml

Omnipaque Stungulyf, lausn 140 mg J/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omnipaque stungulyf, lausn 140 mg j/ml

ge healthcare as - iohexolum inn - stungulyf, lausn - 140 mg j/ml

Decortin H Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

decortin h tafla 5 mg

merck ab - prednisolonum inn - tafla - 5 mg